Document is current
Any future updates will be listed below
-
Authors
Miura, Yuya
Ohnami, Sumiko
Ohshima, Keiichi
Nagashima, Takeshi
Okamura, Yukiyasu
Hatakeyama, Keiichi
Urakami, Kenichi
Akiyama, Yasuto
Ashida, Ryo
Ohgi, Katsuhisa
Kato, Yoshiyasu
Otsuka, Shimpei
Dei, Hideyuki
Uesaka, Katsuhiko
Yamaguchi, Ken
Sugiura, Teiichi
- License Information
-
More Information
Article History
Received: 27 August 2025
Accepted: 29 September 2025
First Online: 14 October 2025
Disclosure
: The authors declare no conflicts of interest in association with the present study.
: The Shizuoka Cancer Center initiated Project HOPE (High-Tech Omics-Based Patient Evaluation) in 2014 to investigate the biological characteristics and pathogenesis of various cancers, following approval from the Institutional Review Board of Shizuoka Cancer Center (approval no. 25-33). Project HOPE was conducted at a single institution and was designed in accordance with the Ethical Guidelines for Human Genome and Genetic Analysis Research, as revised in 2013. Written informed consent was obtained from all patients participating in Project HOPE.
